Načítá se...
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
Chemoembolization for hepatocellular carcinoma (HCC) is often suboptimal due to multiple involved signaling and lack of effective drugs. Arsenic trioxide (ATO) is a potent chemotherapeutic agent, which can target multiple signaling and have substantial efficacy on HCC. However, its usage is limited...
Uloženo v:
| Vydáno v: | Drug Deliv |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7738295/ https://ncbi.nlm.nih.gov/pubmed/33307843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1856219 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|